Award

The Supply of Alliance Solus Pharmaceutical Products

  • Ministry of Defence

F15: Voluntary ex ante transparency notice

Notice identifier: 2024/S 000-001731

Procurement identifier (OCID): ocds-h6vhtk-042e2d

Published 18 January 2024, 12:40pm



Section one: Contracting authority/entity

one.1) Name and addresses

Ministry of Defence

Cedar 2A, Mailpoint #3237, MOD Abbey Wood

Bristol

BS34 8JH

Contact

Jack Hunt

Email

jack.hunt141@teamleidos.mod.uk

Telephone

+44 7974636594

Country

United Kingdom

Region code

UK - United Kingdom

Internet address(es)

Main address

https://www.leidos-supply.uk/

Buyer's address

https://www.leidos-supply.uk/esourcing

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Defence


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

The Supply of Alliance Solus Pharmaceutical Products

Reference number

LSL/MED/0138

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Leidos Supply Ltd. intends to award a single source framework for the provision of Alliance Solus Pharmaceutical Products for the UK Ministry of Defence. The agreement will be for the duration of 3 years.

It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation 32(2)(b)(iii) of Public Contracts Regulations 2015). The Solus products contained within the proposed agreement are only available for purchase through a contract direct with Alliance Healthcare.

Team Leidos/MoD reserve the right to include additional Alliance Solus products into the agreement that fall within the advertised CPV codes.

The estimated 3-year value is £3,360,000 - £8,400,000 GBP.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Lowest offer: £3,360,000 / Highest offer: £8,400,000 taken into consideration

two.2) Description

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products
  • 33610000 - Medicinal products for the alimentary tract and metabolism
  • 33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
  • 33630000 - Medicinal products for dermatology and the musculo-skeletal system
  • 33640000 - Medicinal products for the genitourinary system and hormones
  • 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
  • 33660000 - Medicinal products for the nervous system and sensory organs
  • 33670000 - Medicinal products for the respiratory system
  • 33680000 - Pharmaceutical articles
  • 33690000 - Various medicinal products

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

Team Leidos are proud to be delivering the logistics commodities and services transformation (LCS(T)) Delivery partner Contracts (LCS (T)/0001 dated 16.4.2015) on behalf of the UK Ministry of Defence (the ‘Prime Contract’). Delivery of other parts of the LCS(T) contract are delivered by Leidos Europe Ltd (LEL) and other partners (together ‘Team Leidos’).

Please note all information provided to organisations or individuals that respond to this notice should be treated as Confidential, and not shared further without express written permission from Leidos Supply Ltd.

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Negotiated without a prior call for competition

  • The products involved are manufactured purely for the purpose of research, experiment, study or development
  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • protection of exclusive rights, including intellectual property rights

Explanation:

It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (2)(b)(iii) of Directive 2014/24/EC of the European Parliament (Regulation 32(2)(b)(iii) of Public Contracts Regulations 2015). The Solus products contained within the proposed agreement are only available for purchase through a contract direct with Alliance Healthcare.

Team Leidos/MoD reserve the right to include additional Alliance Solus products into the agreement that fall within the advertised CPV codes.

four.1.3) Information about a framework agreement

The procurement involves the establishment of a framework agreement

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract/concession

Contract No

LSL/MED/0138

Title

The Supply of Alliance Solus Pharmaceutical Products

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

15 January 2024

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Alliance Healthcare

43 Cox Lane, Chessington

Surrey

KT9 1SN

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

03446039

Internet address

https://www.alliance-healthcare.co.uk/

The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Lowest offer: £3,360,000 / Highest offer: £8,400,000 taken into consideration

five.2.5) Information about subcontracting

The contract/lot/concession is likely to be subcontracted


Section six. Complementary information

six.3) Additional information

The authority reserves the right to amend any condition related to security of information to reflect any changes in national law or government policy. If any contract documents are accompanied by instructions on safeguarding classified information (e.g. a security aspects letter), the authority reserves the right to amend the terms of these instructions to reflect any changes in national law or government policy, whether in respect of the applicable protective marking scheme, specific protective markings given, the aspects to which any protective marking applies, or otherwise. The link below to the Gov.uk website provides information on the Government Security Classification.

https://www.gov.uk/government/publications/government-security-classifications

six.4) Procedures for review

six.4.1) Review body

Leidos Supply Ltd

Bristol

Email

Jack.hunt141@teamleidos.mod.uk

Country

United Kingdom